The review assessed treatments for pain relief after laparoscopic cholecystectomy. The author concluded that treatment should consist of a dose of dexamethasone before surgery together with local anaesthetics at the incision and nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors for a few days after surgery. The conclusions went beyond the evidence, which was systematically reviewed and might not be impartial.
were evaluated by an independent assessor.
Data extraction
The author did not state how the data were extracted for the review, or how many reviewers performed the data extraction.
The data were expressed as either a significant difference or no significant difference between the treatment and control.
Methods of synthesis
How were the studies combined? The included studies were grouped according to the type of intervention and listed in tables, using symbols to denote significant and no significant difference in outcomes between treatment and control, together with a narrative critique of the findings. In addition, the effects of treatment on incisional, visceral and shoulder pain were summarised across the included studies. The conclusions were said to be based on studies of good or moderate quality.
How were differences between studies investigated?
Studies of local anaesthetics were grouped as incisional, intraperitoneal or both versus placebo, or incisional versus intraperitoneal. The remaining studies were grouped under NSAIDs/COX-2 inhibitors, opioids, steroids, epidural analgesia, intrathecal local anaesthetic/morphine, gabapentin, clonidine, NMDA receptor antagonists, or multimodal analgesia.
Results of the review
Sixty-four RCTs (5,018 participants) were included in the review.
NSAIDs/COX-2 inhibitors.
Six trials of NSAIDs and two of COX-2 inhibitors showed significant effects on pain and/or opioid needs compared with placebo. Study quality was moderate or poor in all but one trial. One poor-quality trial showed no difference between NSAIDs and acetaminophen (paracetamol). Pre-operative intravenous ketoprofen significantly reduced pain and opioid needs in comparison with post-operative administration (1 good-quality trial).
Local anaesthetics.
Six out of 8 trials of incisional local anaesthetics showed a significant effect on pain compared with placebo, while treatment had a significant opioid-sparing effect in 4 trials. The quality of these trials was moderate or poor.
The effect of intraperitoneal local anaesthetics on pain and opioid needs was inconsistent across 24 trials. Fifteen trials (1 good quality) showed a significant difference in at least one outcome in favour of treatment compared with placebo, whereas 9 trials (1 good quality) found no difference. The trial protocols varied considerably.
Two good-quality trials of incisional and intraperitoneal local anaesthesia together showed a significant effect on incisional pain, but not on shoulder or visceral pain. In one of the trials overall pain and opioid need was reduced in the first 2 or 3 hours after surgery. The trials varied in the dose, site and timing of the intervention.
Opioids.
Opioids were compared with placebo in 3 trials. One poor-quality trial showed a significant reduction in the need for additional opioids but no effect on pain, whereas 2 moderate-quality trials found no difference in either outcome. Opioids were compared with alternative opioid regimens in 4 trials. One good-quality trial showed better post-operative pain control when treatment was given at the beginning rather than at the end of surgery. One good-quality trial showed a significant effect on both outcomes with intraperitoneal versus intramuscular pethidine. Two moderate-quality trials found no difference in effect between alternative regimens. Steroids.
One good-quality placebo-controlled trial of dexamethasone showed a significant reduction in overall, incisional and visceral pain, but not shoulder pain, and a significant reduction in opioid needs.
Epidural analgesics.
Pain was significantly reduced by epidural analgesia compared with unspecified controls in 2 poor-quality trials. Pain and opioid needs were significantly reduced by intrathecal local anaesthesia/morphine in one moderate-quality placebocontrolled trial.
Gabapentin.
Pre-operative gabapentin significantly reduced pain and opioid consumption compared with placebo or tramadol in one moderate-quality trial.
Clonidine.
Clonidine was compared with placebo in 2 poor-quality trials. One showed that treatment significantly reduced postoperative pain. Both trials showed a significant difference in opioid needs.
NMDA receptor antagonists.
Significant beneficial effects on pain and opioid needs were shown in 3 trials of dextromethorphan compared with placebo and/or intravenous lidocaine or tramadol. The trials were of moderate or poor quality. Two trials, one poor and one moderate quality, found no difference between ketamine and placebo or tramadol.
Multimodal strategies.
Multimodal analgesia comprising pre-operative intramuscular opioids, ketorolac, and incisional-intraperitoneal local anaesthetic blockade significantly reduced pain and opioid needs compared with placebo in one moderate-quality trial.
Interventions to reduce incisional, visceral and shoulder pain.
Few trials investigated the different components of post-operative pain following laparoscopic cholecystectomy. On the basis of the aforementioned studies included in the review, incisional local anaesthetics and dexamethasone reduced incisional pain, while intraperitoneal local anaesthetics and dexamethasone reduced visceral pain. Evidence for the treatment of shoulder pain was lacking.
